SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BZC'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_A_NCAA700_0 (EXOTOXIN A)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	5 / 7	HIS A 862 GLY A 863 TYR A 896 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.51A	1dmaA-1efyA: 5.8	1dmaA-1efyA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_B_NCAB700_0 (EXOTOXIN A)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	6 / 6	HIS A 862 GLY A 863 TYR A 896 ALA A 898 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.44A	1dmaB-1efyA: 5.6	1dmaB-1efyA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	7 / 8	HIS A 862 GLY A 863 ALA A 898 LYS A 903 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	1.25A	3u9hA-1efyA: 19.0	3u9hA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	7 / 8	HIS A 862 GLY A 863 TYR A 896 ALA A 898 LYS A 903 SER A 904 TYR A 907	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A)	0.92A	3u9hA-1efyA: 19.0	3u9hA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	7 / 8	HIS A 862 GLY A 863 ALA A 898 LYS A 903 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	1.24A	3u9hB-1efyA: 19.0	3u9hB-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	7 / 8	HIS A 862 GLY A 863 TYR A 896 ALA A 898 LYS A 903 SER A 904 TYR A 907	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A)	0.96A	3u9hB-1efyA: 19.0	3u9hB-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	5 / 6	HIS A 862 GLY A 863 TYR A 896 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.43A	4ae1A-1efyA: 6.4	4ae1A-1efyA: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	5 / 5	HIS A 862 GLY A 863 TYR A 896 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.46A	4ae1B-1efyA: 0.1	4ae1B-1efyA: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	6 / 8	HIS A 862 GLY A 863 ALA A 898 LYS A 903 SER A 904 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-4.0A)	1.30A	4bjcA-1efyA: 18.7	4bjcA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	6 / 8	HIS A 862 GLY A 863 ALA A 898 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 ( 3.9A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.78A	4bjcA-1efyA: 18.7	4bjcA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	6 / 8	HIS A 862 GLY A 863 TYR A 896 ALA A 898 LYS A 903 SER A 904	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A)	0.91A	4bjcA-1efyA: 18.7	4bjcA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	6 / 8	HIS A 862 GLY A 863 TYR A 896 ALA A 898 SER A 904 TYR A 907	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 (-3.3A) BZC A 201 (-3.6A)	0.27A	4bjcA-1efyA: 18.7	4bjcA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_A_NCAA1201_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	7 / 7	HIS A 862 GLY A 863 TYR A 896 ALA A 898 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.58A	4hyfA-1efyA: 19.9	4hyfA-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_B_NCAB1201_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	8 / 8	HIS A 862 GLY A 863 TYR A 896 ALA A 898 LYS A 903 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.86A	4hyfB-1efyA: 20.0	4hyfB-1efyA: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_C_NCAC1201_0 (TANKYRASE-2)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	8 / 8	HIS A 862 GLY A 863 TYR A 896 ALA A 898 LYS A 903 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.53A	4hyfC-1efyA: 20.0	4hyfC-1efyA: 23.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	5 / 11	GLN A 763 TYR A 896 ALA A 898 LYS A 903 GLU A 988	BZC A 201 (-3.8A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-4.0A)	0.92A	4rv6A-1efyA: 52.2	4rv6A-1efyA: 86.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	9 / 11	HIS A 862 GLY A 863 TYR A 889 TYR A 896 ALA A 898 LYS A 903 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) None BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.50A	4rv6A-1efyA: 52.2	4rv6A-1efyA: 86.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	5 / 11	GLN A 763 TYR A 896 ALA A 898 LYS A 903 GLU A 988	BZC A 201 (-3.8A) BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-4.0A)	0.93A	4rv6B-1efyA: 52.4	4rv6B-1efyA: 86.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	9 / 11	HIS A 862 GLY A 863 TYR A 889 TYR A 896 ALA A 898 LYS A 903 SER A 904 TYR A 907 GLU A 988	BZC A 201 (-4.0A) BZC A 201 (-3.9A) None BZC A 201 (-4.0A) BZC A 201 ( 3.9A) BZC A 201 ( 4.8A) BZC A 201 (-3.3A) BZC A 201 (-3.6A) BZC A 201 (-4.0A)	0.49A	4rv6B-1efyA: 52.4	4rv6B-1efyA: 86.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	1efy	POLY (ADP-RIBOSE) POLYMERASE (Gallus gallus)	8 / 9	ASP A 770 HIS A 862 SER A 864 ASN A 868 ILE A 872 TYR A 896 SER A 904 TYR A 907	None BZC A 201 (-4.0A) None None None BZC A 201 (-4.0A) BZC A 201 (-3.3A) BZC A 201 (-3.6A)	0.55A	5ha9B-1efyA: 50.7	5ha9B-1efyA: 86.86

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DMA_A_NCAA700_0","EXOTOXIN A","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",5,"HIS A 862;GLY A 863;TYR A 896;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.51A","1dmaA-1efyA:5.8",null],["1DMA_B_NCAB700_0","EXOTOXIN A","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",6,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.44A","1dmaB-1efyA:5.6","1dmaA-1efyA:20.23"],["3U9H_A_NCAA1163_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",7,"HIS A 862;GLY A 863;ALA A 898;LYS A 903;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","1.25A","3u9hA-1efyA:19.0","1dmaB-1efyA:20.23"],["3U9H_A_NCAA1163_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",7,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;LYS A 903;SER A 904;TYR A 907","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A)","0.92A","3u9hA-1efyA:19.0","3u9hA-1efyA:23.42"],["3U9H_B_NCAB1164_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",7,"HIS A 862;GLY A 863;ALA A 898;LYS A 903;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","1.24A","3u9hB-1efyA:19.0","3u9hA-1efyA:23.42"],["3U9H_B_NCAB1164_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",7,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;LYS A 903;SER A 904;TYR A 907","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A)","0.96A","3u9hB-1efyA:19.0","3u9hB-1efyA:23.42"],["4AE1_A_NCAA1536_0","DIPHTHERIA TOXIN","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",5,"HIS A 862;GLY A 863;TYR A 896;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.43A","4ae1A-1efyA:6.4","3u9hB-1efyA:23.42"],["4AE1_B_NCAB1536_0","DIPHTHERIA TOXIN","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",5,"HIS A 862;GLY A 863;TYR A 896;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.46A","4ae1B-1efyA:0.1","4ae1A-1efyA:21.45"],["4BJC_A_RPBA2162_1","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",6,"HIS A 862;GLY A 863;ALA A 898;LYS A 903;SER A 904;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-4.0A)","1.30A","4bjcA-1efyA:18.7","4ae1B-1efyA:21.45"],["4BJC_A_RPBA2162_1","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",6,"HIS A 862;GLY A 863;ALA A 898;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 ( 3.9A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.78A","4bjcA-1efyA:18.7","4bjcA-1efyA:23.42"],["4BJC_A_RPBA2162_1","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",6,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;LYS A 903;SER A 904","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A)","0.91A","4bjcA-1efyA:18.7","4bjcA-1efyA:23.42"],["4BJC_A_RPBA2162_1","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",6,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;SER A 904;TYR A 907","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 (-3.3A);BZC A 201 (-3.6A)","0.27A","4bjcA-1efyA:18.7","4bjcA-1efyA:23.42"],["4HYF_A_NCAA1201_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",7,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.58A","4hyfA-1efyA:19.9","4bjcA-1efyA:23.42"],["4HYF_B_NCAB1201_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",8,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;LYS A 903;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.86A","4hyfB-1efyA:20.0","4hyfA-1efyA:23.42"],["4HYF_C_NCAC1201_0","TANKYRASE-2","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",8,"HIS A 862;GLY A 863;TYR A 896;ALA A 898;LYS A 903;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.53A","4hyfC-1efyA:20.0","4hyfB-1efyA:23.42"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",5,"GLN A 763;TYR A 896;ALA A 898;LYS A 903;GLU A 988","BZC A 201 (-3.8A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-4.0A)","0.92A","4rv6A-1efyA:52.2","4hyfC-1efyA:23.42"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",9,"HIS A 862;GLY A 863;TYR A 889;TYR A 896;ALA A 898;LYS A 903;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);None;BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.50A","4rv6A-1efyA:52.2","4rv6A-1efyA:86.57"],["4RV6_B_RPBB1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",5,"GLN A 763;TYR A 896;ALA A 898;LYS A 903;GLU A 988","BZC A 201 (-3.8A);BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-4.0A)","0.93A","4rv6B-1efyA:52.4","4rv6A-1efyA:86.57"],["4RV6_B_RPBB1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",9,"HIS A 862;GLY A 863;TYR A 889;TYR A 896;ALA A 898;LYS A 903;SER A 904;TYR A 907;GLU A 988","BZC A 201 (-4.0A);BZC A 201 (-3.9A);None;BZC A 201 (-4.0A);BZC A 201 ( 3.9A);BZC A 201 ( 4.8A);BZC A 201 (-3.3A);BZC A 201 (-3.6A);BZC A 201 (-4.0A)","0.49A","4rv6B-1efyA:52.4","4rv6B-1efyA:86.57"],["5HA9_B_TP0B406_1","POLY [ADP-RIBOSE] POLYMERASE 1","1efy","POLY (ADP-RIBOSE) POLYMERASE","Gallus gallus",8,"ASP A 770;HIS A 862;SER A 864;ASN A 868;ILE A 872;TYR A 896;SER A 904;TYR A 907","None;BZC A 201 (-4.0A);None;None;None;BZC A 201 (-4.0A);BZC A 201 (-3.3A);BZC A 201 (-3.6A)","0.55A","5ha9B-1efyA:50.7","4rv6B-1efyA:86.57"]]